Production (Stage)
Barinthus Biotherapeutics plc
BRNS
$0.859
$0.0293.49%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 99.12M | 110.66M | 106.10M | 117.77M | 129.97M |
| Total Receivables | 3.86M | 7.14M | 21.02M | 5.67M | 6.39M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.01M | 5.86M | 7.06M | 7.81M | 5.09M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.90M | 2.08M | 464.00K | 626.00K | 1.68M |
| Total Current Assets | 109.88M | 125.74M | 134.65M | 131.88M | 143.13M |
|
|
|||||
| Total Current Assets | 109.88M | 125.74M | 134.65M | 131.88M | 143.13M |
| Net Property, Plant & Equipment | 10.06M | 11.76M | 18.16M | 18.25M | 18.94M |
| Long-term Investments | -- | -- | 12.21M | 12.21M | 12.21M |
| Goodwill | -- | -- | 12.21M | 12.21M | 12.21M |
| Total Other Intangibles | 21.16M | 21.95M | 22.74M | 23.53M | 24.32M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 902.00K | 881.00K | 926.00K | 886.00K | 885.00K |
| Total Assets | 142.00M | 160.33M | 188.69M | 186.75M | 199.48M |
|
|
|||||
| Total Accounts Payable | 1.36M | 2.47M | 3.08M | 2.56M | 1.16M |
| Total Accrued Expenses | 7.20M | 9.53M | 7.97M | 10.28M | 8.33M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.96M | 1.92M | 1.99M | 1.92M | 1.91M |
| Total Finance Division Other Current Liabilities | 1.46M | 1.74M | 2.04M | 839.00K | 1.43M |
| Total Other Current Liabilities | 1.46M | 1.74M | 2.04M | 839.00K | 1.43M |
| Total Current Liabilities | 11.98M | 15.66M | 15.07M | 15.59M | 12.84M |
|
|
|||||
| Total Current Liabilities | 11.98M | 15.66M | 15.07M | 15.59M | 12.84M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 9.96M | 10.09M | 10.68M | 10.65M | 10.90M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.47M | 4.45M | 3.47M | 3.72M | 3.73M |
| Total Liabilities | 26.40M | 30.19M | 29.23M | 29.96M | 27.47M |
|
|
|||||
| Common Stock & APIC | 393.95M | 393.48M | 391.88M | 390.27M | 388.72M |
| Retained Earnings | -257.31M | -237.66M | -217.12M | -209.01M | -192.08M |
| Treasury Stock & Other | -21.14M | -25.78M | -15.47M | -24.65M | -24.81M |
| Total Common Equity | 115.49M | 130.03M | 159.29M | 156.62M | 171.83M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 115.49M | 130.03M | 159.29M | 156.62M | 171.83M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 99.00K | 106.00K | 167.00K | 172.00K | 183.00K |
| Total Equity | 115.59M | 130.14M | 159.46M | 156.79M | 172.02M |
|
|
|||||